Cas:50917-32-3 5-Amino-2,3-dichlorobenzoic acid manufacturer & supplier

Chemical Name:5-Amino-2,3-dichlorobenzoic acid

CAS.NO:50917-32-3

Synonyms:5-Amino-2,3-dichlorobenzoic acid

Molecular Formula:C₇H₅Cl₂NO₂

Molecular Weight:206.02600

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:404.9ºC at 760 mmHg

Density:1.607g/cm3

Index of Refraction:1.658

PSA:63.32000

Exact Mass:204.97000

LogP:2.85500

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 5-Amino-2,3-dichlorobenzoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Amino-2,3-dichlorobenzoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-Amino-2,3-dichlorobenzoic acid Use and application,5-Amino-2,3-dichlorobenzoic acid technical grade,usp/ep/jp grade.

Related News: Especially tumor drugs with selective targeting characteristics. At present, about 80% of small drug (high-efficiency drug) APIs worldwide are patented drugs. 5-Amino-2,3-dichlorobenzoic acid manufacturer Most foreign drugmakers offered Beijing the lowest prices globally in a recent round of negotiations in order to get some of their new products included in national insurance program, a move that will help them gain access to more patients in less-affluent cities, officials said on Thursday. 5-Amino-2,3-dichlorobenzoic acid supplier It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion. 5-Amino-2,3-dichlorobenzoic acid vendor It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion. 5-Amino-2,3-dichlorobenzoic acid factory It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion.